Modeling Central Nervous System Injury In Vitro: Current Status and Promising Future Strategies

The central nervous system (CNS) injury, which occurs because of mechanical trauma or ischemia/hypoxia, is one of the main causes of mortality and morbidity in the modern society. Until know, despite the fact that numerous preclinical and clinical studies have been undertaken, no significant neuropr...

Full description

Bibliographic Details
Main Authors: Kristina Pilipović, Anja Harej Hrkać, Natalia Kučić, Jasenka Mršić-Pelčić
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/1/94
_version_ 1797445706676436992
author Kristina Pilipović
Anja Harej Hrkać
Natalia Kučić
Jasenka Mršić-Pelčić
author_facet Kristina Pilipović
Anja Harej Hrkać
Natalia Kučić
Jasenka Mršić-Pelčić
author_sort Kristina Pilipović
collection DOAJ
description The central nervous system (CNS) injury, which occurs because of mechanical trauma or ischemia/hypoxia, is one of the main causes of mortality and morbidity in the modern society. Until know, despite the fact that numerous preclinical and clinical studies have been undertaken, no significant neuroprotective strategies have been discovered that could be used in the brain trauma or ischemia treatment. Although there are many potential explanations for the failure of those studies, it is clear that there are questions regarding the use of experimental models, both in vivo and in vitro, when studying CNS injury and searching new therapeutics. Due to some ethical issues with the use of live animals in biomedical research, implementation of experimental strategies that prioritize the use of cells and tissues in the in vitro environment has been encouraged. In this review, we examined some of the most commonly used in vitro models and the most frequently utilized cellular platforms in the research of traumatic brain injury and cerebral ischemia. We also proposed some future strategies that could improve the usefulness of these studies for better bench-to-bedside translational outcomes.
first_indexed 2024-03-09T13:30:41Z
format Article
id doaj.art-e72c234c55a04893a83d62ec861bca62
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-09T13:30:41Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-e72c234c55a04893a83d62ec861bca622023-11-30T21:19:21ZengMDPI AGBiomedicines2227-90592022-12-011119410.3390/biomedicines11010094Modeling Central Nervous System Injury In Vitro: Current Status and Promising Future StrategiesKristina Pilipović0Anja Harej Hrkać1Natalia Kučić2Jasenka Mršić-Pelčić3Department of Basic and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, CroatiaDepartment of Basic and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, CroatiaDepartment of Physiology and Immunology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, CroatiaDepartment of Basic and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, CroatiaThe central nervous system (CNS) injury, which occurs because of mechanical trauma or ischemia/hypoxia, is one of the main causes of mortality and morbidity in the modern society. Until know, despite the fact that numerous preclinical and clinical studies have been undertaken, no significant neuroprotective strategies have been discovered that could be used in the brain trauma or ischemia treatment. Although there are many potential explanations for the failure of those studies, it is clear that there are questions regarding the use of experimental models, both in vivo and in vitro, when studying CNS injury and searching new therapeutics. Due to some ethical issues with the use of live animals in biomedical research, implementation of experimental strategies that prioritize the use of cells and tissues in the in vitro environment has been encouraged. In this review, we examined some of the most commonly used in vitro models and the most frequently utilized cellular platforms in the research of traumatic brain injury and cerebral ischemia. We also proposed some future strategies that could improve the usefulness of these studies for better bench-to-bedside translational outcomes.https://www.mdpi.com/2227-9059/11/1/94brain injuriestraumaticbrain ischemia/hypoxiacell culture techniquesinduced pluripotent stem cellsthe central nervous system
spellingShingle Kristina Pilipović
Anja Harej Hrkać
Natalia Kučić
Jasenka Mršić-Pelčić
Modeling Central Nervous System Injury In Vitro: Current Status and Promising Future Strategies
Biomedicines
brain injuries
traumatic
brain ischemia/hypoxia
cell culture techniques
induced pluripotent stem cells
the central nervous system
title Modeling Central Nervous System Injury In Vitro: Current Status and Promising Future Strategies
title_full Modeling Central Nervous System Injury In Vitro: Current Status and Promising Future Strategies
title_fullStr Modeling Central Nervous System Injury In Vitro: Current Status and Promising Future Strategies
title_full_unstemmed Modeling Central Nervous System Injury In Vitro: Current Status and Promising Future Strategies
title_short Modeling Central Nervous System Injury In Vitro: Current Status and Promising Future Strategies
title_sort modeling central nervous system injury in vitro current status and promising future strategies
topic brain injuries
traumatic
brain ischemia/hypoxia
cell culture techniques
induced pluripotent stem cells
the central nervous system
url https://www.mdpi.com/2227-9059/11/1/94
work_keys_str_mv AT kristinapilipovic modelingcentralnervoussysteminjuryinvitrocurrentstatusandpromisingfuturestrategies
AT anjaharejhrkac modelingcentralnervoussysteminjuryinvitrocurrentstatusandpromisingfuturestrategies
AT nataliakucic modelingcentralnervoussysteminjuryinvitrocurrentstatusandpromisingfuturestrategies
AT jasenkamrsicpelcic modelingcentralnervoussysteminjuryinvitrocurrentstatusandpromisingfuturestrategies